KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 180 filers reported holding KARUNA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $103,836,486 | +73.0% | 328,067 | +18.6% | 0.02% | +50.0% |
| Q2 2023 | $60,004,780 | -4.5% | 276,711 | -20.0% | 0.01% | -14.3% |
| Q1 2023 | $62,837,268 | +2.7% | 345,944 | +11.1% | 0.01% | -6.7% |
| Q4 2022 | $61,206,803 | +4.2% | 311,485 | +19.3% | 0.02% | -6.2% |
| Q3 2022 | $58,731,247 | +134.9% | 261,109 | +32.1% | 0.02% | +166.7% |
| Q2 2022 | $25,007,611 | -0.7% | 197,673 | -0.5% | 0.01% | +20.0% |
| Q1 2022 | $25,188,355 | -9.7% | 198,662 | -6.7% | 0.01% | -16.7% |
| Q4 2021 | $27,885,000 | +24.1% | 212,862 | +15.9% | 0.01% | +20.0% |
| Q3 2021 | $22,465,000 | +22.5% | 183,640 | +14.1% | 0.01% | +25.0% |
| Q2 2021 | $18,342,000 | +105.0% | 160,909 | +116.2% | 0.00% | +100.0% |
| Q1 2021 | $8,947,000 | -50.9% | 74,414 | -58.5% | 0.00% | -50.0% |
| Q4 2020 | $18,216,000 | +33.8% | 179,307 | +1.8% | 0.00% | 0.0% |
| Q3 2020 | $13,616,000 | +6708.0% | 176,094 | +1660.9% | 0.00% | – |
| Q2 2019 | $200,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 1,885,602 | $135,763,000 | 12.56% |
| PFM Health Sciences, LP | 499,510 | $35,965,000 | 2.95% |
| Eventide Asset Management | 901,077 | $64,878,000 | 2.10% |
| ACUTA CAPITAL PARTNERS, LLC | 56,000 | $4,032,000 | 1.95% |
| Logos Global Management LP | 69,658 | $5,015,000 | 1.91% |
| Vivo Capital, LLC | 223,692 | $16,106,000 | 1.46% |
| Atika Capital Management LLC | 90,000 | $6,480,000 | 1.24% |
| EAM Global Investors LLC | 27,126 | $1,953,000 | 1.14% |
| EAM Investors, LLC | 40,516 | $2,917,000 | 0.91% |
| MOODY ALDRICH PARTNERS LLC | 25,844 | $1,861,000 | 0.56% |